Niki BioSolutions, Inc. (NIKI) bonds
NIKINasdaqMeasuring & Controlling Devices, NECFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2025, quý kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 27, 2026Score 4/30
$1.60+0.10 (+6.67%)
Close on Nov 18, 2026Market cap $13.03MP/E –Yield –
Debt
Borrowings on the balance sheet, Dec 31, 2025
Niki BioSolutions reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Niki BioSolutions's 20-F for the period ended Sep 11, 2023
| Issue | Coupon | Amount issued |
|---|---|---|
| Convertible Notes Convertible | – | $3.00M |
| June Two Thousand Twenty Three Notes Convertible at $3 a share | 7.00% | – |
| Sep Two Thousand Twenty Three Notes Convertible at $2 a share | 6.00% | – |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 20-F.
See a number that looks wrong?